Recombinant Human F2RL3 Protein，GST

F2RL3, also known as the protease-activated receptor 4 (PAR4), is a member of the protease-activated receptor family, which plays a crucial role in various physiological processes, including hemostasis, inflammation, and tissue repair. Recent research has focused on understanding the functional implications of F2RL3 in both health and disease states, particularly its involvement in cardiovascular diseases, cancer, and autoimmune disorders. The receptor is activated by coagulation factors, specifically thrombin, which triggers intracellular signaling cascades that modulate cellular responses. Given its significant role in platelet activation and vascular integrity, F2RL3 has emerged as a potential therapeutic target for drug development. Researchers have been particularly interested in the characterizations of its signaling pathways and the development of F2RL3-recombinant proteins to study receptor function and interaction with various ligands. Understanding the structural biology of F2RL3 is essential for elucidating its function and potential roles in pathophysiological conditions. Moreover, engineered recombinant proteins can facilitate high-throughput screening in drug discovery efforts, providing insights into novel inhibitors or modulators of F2RL3 activity. This research is pivotal in expanding our knowledge of G protein-coupled receptors and their contributions to human health, potentially leading to innovative therapeutic strategies in treating related diseases.